Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
The Burrill Report
»
Articles
»
ABT
|
The Burrill Report
187
Followers
2
Following
You are currently following The Burrill Report
Stop Following
You are no longer following The Burrill Report
Profile
Articles (49)
Big Pharma Willing to Pay for Biotech Innovation
on Nov 15, 2009
•
ABT
,
ALPMF.PK
,
BMY
Capital Markets Open Up to Biotechs
on Oct 04, 2009
•
ABT
,
GSK
,
JNJ
Financing Activity for Biotech Deals Heats Up
on Sep 27, 2009
•
ABT
,
AZN
,
BIIB
Biotech Busy with Bevy of Small Deals
on Sep 12, 2009
•
ABT
,
AMLN
,
CADX
Summer Ends with Biotech Buying Spree
on Sep 06, 2009
•
ABT
,
BIIB
,
CELG
July Was a Good Month for Biotech
on Aug 02, 2009
•
A
,
ABT
,
AMGN
Redefining Pharma as Biotech Dominates Industry's Growth
on Jun 21, 2009
•
ABT
,
AMGN
,
JNJ
More on ABT by The Burrill Report
Instablogs »
StockTalks »
Comments »
Articles by Ticker
A
,
ABT
,
ACOR
,
ADM
,
AFPC
,
ALDH
,
ALIOF.PK
,
ALPMF.PK
,
ALTU
,
AMGN
,
AMLN
,
ANDS
,
ANSV
,
APPA
,
ARIA
,
ARYX
,
AVGN
,
AVII
,
AZN
,
BFRE.OB
,
BIIB
,
BMTI
,
BMY
,
BPA
,
BVF
,
BYERF.PK
,
CADX
,
CCM
,
CEGE
,
CELG
,
CGRB
,
CLDA
,
CLDX
,
CNSO.OB
,
CPIX
,
CRA
,
CRGN
,
CRXX
,
CTIC
,
CVM
,
CYTK
,
CYTX
,
DCGN
,
DHR
,
DNA
,
DNDN
,
DYAX
,
EDEN
,
ELN
,
ELXR
,
EM
,
ENDP
,
EPIX
,
ESRX
,
EXEL
,
FACT
,
FRX
,
GE
,
GENZ
,
GERN
,
GETA.OB
,
GNMSF.PK
,
GSK
,
HALO
,
HGSI
,
HLCS
,
HNAB
,
ICGN
,
IDIX
,
IMCL
,
IMGN
,
IMMU
,
INCY
,
INHX
,
ISIS
,
ISPH
,
ITMN
,
IYH
,
IYR
,
JNJ
,
KERX
,
LGND
,
LIFE
,
LJPC
,
LLY
,
LXRX
,
LZAGF.PK
,
MAPP
,
MATK
,
MBRX
,
MDVN
,
MDZ
,
MEDX
,
MIPI
,
MITI
,
MJN
,
MNKD
,
MNOV
,
MRK
,
MSFT
,
MYL
,
NABI
,
NKBP
,
NKTR
,
NVO
,
NVS
,
OMER
,
ONXX
,
OPXA
,
OREX
,
OSCI
,
PARD
,
PEIX
,
PFE
,
PG
,
PKNGF.PK
,
PPDI
,
PRU
,
QGEN
,
RDY
,
REGN
,
RGEN
,
RHHBY.PK
,
RIGL
,
RPRX
,
RXII
,
SEM
,
SEPR
,
SGEN
,
SGMO
,
SGP
,
SHPGY
,
SLF
,
SLFPF.PK
,
SNY
,
SOMX
,
SPHDF.PK
,
STEM
,
SUPG
,
SVNT
,
SVYSY.PK
,
SYT
,
TEVA
,
TGEN
,
TKPHF.PK
,
TLCR
,
TMO
,
TPTX
,
TRBN
,
TRGT
,
TSMA
,
TSPT
,
TTP
,
UGNE.OB
,
VAR
,
VRNM
,
VRTX
,
VRX
,
VVUS
,
WCRX
,
WPI
,
WYE
,
XLV
,
ZGEN
Latest Comments on The Burrill Report's Articles
xinyue296320
on
Making and Breaking Biotech Deals
: 50%off ca,ed hardy t-shirt$15 jeans,coach handbag$33,air...
more »
Alessandro
on
BlueFire, Archer Daniels to Benefit from Federal Biorefinery Millions
: I saw a television special espousing the benefits of biochar and...
more »
Alessandro
on
BlueFire, Archer Daniels to Benefit from Federal Biorefinery Millions
: On Dec 13 07:47 PM auto44 wrote: > You are supposed to sell BS...
more »
BioGuy
on
Biotech's Latest Failed Trials, Missed Targets
: I think ZymoGenetics was smart to change it's focus to creating...
more »
Erich J Knight
on
BlueFire, Archer Daniels to Benefit from Federal Biorefinery Millions
: All political persuasions agree, building soil carbon is GOOD. To...
more »
auto44
on
BlueFire, Archer Daniels to Benefit from Federal Biorefinery Millions
: You are supposed to sell BS not buy it. On Dec 13 10:13 AM...
more »
johnnysize
on
Bristol-Myers Squibb Sees Perfect Timing to Divest Huge Mead Johnson Nutrition Stake
: oh gee...thats option expiration ...wow. maybe now proration...
more »
uncle mike
on
Life Sciences Co. Execs Enjoying Pay Hikes in the Downturn
: bios are always iffee but if you pick them right buy in and out...
more »
valuestocksonly
on
BlueFire, Archer Daniels to Benefit from Federal Biorefinery Millions
: BFRE is going to play a large role in this nations energy...
more »
Walt17
on
Eli Lilly Plans Innovation Strategy to Counter Generics Threat
: Lilly acknowledges the generic competition. Why does this surprise...
more »
User 468179
on
Eli Lilly Plans Innovation Strategy to Counter Generics Threat
: Eli Lilly sells a drug (Zyprexa) that can cause...
more »
johnnysize
on
Bristol-Myers Squibb Sees Perfect Timing to Divest Huge Mead Johnson Nutrition Stake
: Ahhhh...I get it. When the ratio is set and the S4 is effective we...
more »
johnnysize
on
Bristol-Myers Squibb Sees Perfect Timing to Divest Huge Mead Johnson Nutrition Stake
: Is MJN going into the SPX 500?
more »
tonymueller
on
Bristol-Myers Squibb Sees Perfect Timing to Divest Huge Mead Johnson Nutrition Stake
: Again appreciate the help, think i will hold my bmy so I don't...
more »
Adonis
on
Bristol-Myers Squibb Sees Perfect Timing to Divest Huge Mead Johnson Nutrition Stake
: My fault, correction, I was not aware of the extension, so the...
more »
Latest Comments on The Burrill Report's Articles
Latest Comments on The Burrill Report's Articles